Association of human leukocyte antigen groups with oral mucositis in patients undergoing bone marrow transplantation
Authors:
Preprint
- 21 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Oral mucositis (OM) after hematopoetic stem cell transplantation (HSCT) may lead to toxicity that impair quality of life. Associations between some diseases and human leukocyte antigen (HLA) groups have been long recognized. A genetic contribution as the association of HLA groups with OM after HSCT, has not been reported to date. We aimed to assess whether an association of HLA phenotype and OM after allogeneic HSCT exists.Methods: This was a prospective observational study in which OM was assessed with clinical questioning and examination. Association of OM with gender, age, HLA phenotypes, diagnosis, conditioning regimen, stem cell source, engraftment times, and complications was investigated.Results: 45 patients were enrolled. All the patients with HLA-B44 phenotype developed mild OM, while all patients with HLA-DR15 phenotype developed severe OM. HLA-A23, HLA-B21, HLA-B44, HLA-DR15, and HLA-DR11 were associated with shorter OM duration. HLA-A26 and HLA-B52 were associated with longer OM duration. Myeloablative conditioning regimen and longer duration of neutropenia were associated with longer OM duration. Regression analysis revealed HLA-B44 and HLA-DR11 as independent factors associated with milder OM.Conclusion: We identified that some HLA alleles correlated with OM severity and duration. These findings may facilitate predicting risk of morbidity and may provide incorporation of individualized preventive and treatment approaches.Keywords
All Related Versions
- Version 1, 2020-10-21, Research Square
- Published version: Leukemia Research, 85, S52.
This publication has 17 references indexed in Scilit:
- The immunogenetics of Behçet's disease: A comprehensive reviewJournal of Autoimmunity, 2015
- Oral cryotherapy can significantly reduce oral mucositis but not acute GVHD incidence in Flu/Mel conditioning allo-SCTBone Marrow Transplantation, 2011
- A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimensSupportive Care in Cancer, 2011
- Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT—results of a multicentre studyBone Marrow Transplantation, 2010
- A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease ProphylaxisTransplantation and Cellular Therapy, 2010
- Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2Bone Marrow Transplantation, 2009
- The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel diseaseRheumatology International, 2005
- Risk factors for ulcerative oral mucositis in cancer patients: unanswered questionsOral Oncology, 2003
- Risk factors associated with mucositis in cancer patients receiving 5-fluorouracilOral Oncology, 1998
- A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipientsCancer, 1993